Advisory Boards

Chairman's Advisory Board

Scientific Advisory Board

Mark Lubkeman — Chair
Managing Director and Senior Partner, The Boston Consulting Group
Former leader, Global Biopharma Sector and US Healthcare Practice
Former Trustee, California Science Center

Ian Barlow
Non-Executive Director Urban & Civic PLC, Foxtons Group PLC, and The Brunner Investment Trust PLC
Former Non-executive Director at Smith & Nephew PLC
Former London Senior Partner at KPMG

Dan Bricken
Head of US Cross Border Corporate Finance at Investec
Former Managing Director at East West Global Capital
Co-Founder and Board Director at Kindred

Peter Cohen
Former Chairman and Chief Executive Officer at Cowen Inc.
Founder and Former Chief Executive Officer at Ramius Capital Management
Former Chairman and Chief Executive Officer at Shearson Lehman Brothers

Laura Lofaro
Founder and Chief Executive Officer at Sterling Resources International
Former Member of the Board of Trustees, Museum of the City of New York
Guest Lecturer, Columbia University Business School

David Restrepo RPH
President at Vitahealth Apothecary
Integrative Pharmacist

Andrew Willis

Co-founder of Crossix Solutions Inc. (now part of Veeva Systems)
Board of Advisors, Georgetown McDonough School of Business
Board of Advisors, Columbia Business School Healthcare and Pharmaceutical Management Program

John Winter
Chief Executive Officer at MUFG Securities EMEA PLC
Former Chief Executive Officer at Barclays Corporate Bank

Craig Vanderwagen, M.D, Chairman

Former Assistant Secretary for Preparedness and Response at U.S. Department of Health and Human Services

Retired Admiral from U.S. Public Health Service


Andrea Ballabio, Ph.D.

Professor at TIGEM (Italy) International

Expert on modulation of cell clearance for Neurodegenerative Disorders and Lysosomal Storage Disorders treatment 

Stephen Cohen, LAc, MSOM
Founder AXIOM Holistic
Former Mergers and Acquisitions Transaction Advisor

Marc Patterson, M.D.

Professor of Neurology and Chair of the Division of Child and Adolescent Neurology at Mayo Clinic, Rochester, Minnesota

Research and practice focus on children with rare diseases including Niemann-Pick Disease type C (NPC) and GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease)


Bill Raub, Ph.D.

Former Acting Director of the National Institutes of Health

Former Scientific Advisor to HHS Secretary